Skip to main content

Immune Response BioPharma, Inc.

Home
Drug Discovery
Press Releases
Investor Relations
Royalties
Stock Information
Executive Team
Scientific Board
Clinical Trials
REMUNE Vaccine
REMUNE Rx Co-pay Card
REMUNE FULL PRESCRIBING
REMUNEX Vaccine
Remune Pediatric
RemuneVax Vaccine
NeuroVax Vaccine
NeurOral
RAVAX Vaccine
RAVAX II Vaccine
Zorcell Vaccine
DermaVax
Immunereszumab
Sepsicillin
Rare Diseases
Alliances
Vaccines Direct
Partnering
Bio Defense
Immune Response Hospital
Orchestra Therapeutics
Research Donations
About Us
Corporate Filings
Corporate ByLaws
Transfer Agent
Employment
Events
Webcast
Contact Us
Email Alerts
Member Login
Site Map

Immune Response BioPharma, Inc. TM


Drug Discovery Pipeline: IL-1 Beta Candidate Immunereszumab  TM

 © 2010-2017

undefined

 

Immune Response BioPharma, Inc.

World Class Antibody & Vaccine Technology

 

 

 

Immunereszumab IL-1 Candidate Indications

 

GoutVax TM: Gout Vaccine IL-1 Beta Candidate ImmunereszumabTM

                      Pre-Clinical Studies

 

 

 

 

DiabetesVax TM: Diabetes Vaccine IL-1 Beta Candidate ImmunereszumabTM

                            Pre-Clinical Studies

 

 

 

HeartVax TM:  Cardiology Anti-Cholesterol Drug IL-1 Beta Candidate ImmunereszumabTM

                       Pre-Clinical Studies

 

 

Immune Response BioPharma, Inc. TM

Copyright © 2010-2017        All Rights Reserved          www.immuneresponse.net